Latest / Pharmacy Podcast Network / ASX 25: Access to Pharmacy in Las Vegas | Part Three sponsored by Lumicera
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession. Welcome to the Pharmacy podcast Network.
- 0:28Speaker 2: Welcome to part three of our Assembia twenty five series,
- 0:31Speaker 2: where we've been sharing key conversations from this year's Access
- 0:34Speaker 2: to Pharmacy conference in Las Vegas. Throughout this series, we've
- 0:38Speaker 2: heard from both exhibitors and attendees about the trends, challenges,
- 0:42Speaker 2: and innovations shaping the pharmacy space. Today, we're wrapping things
- 0:46Speaker 2: up with a final round of insights, brought to you
- 0:49Speaker 2: by prim RX. Thanks for joining us throughout this series.
- 0:52Speaker 2: Now here's part.
- 0:53Speaker 3: Three PRIMARX here at Access twenty five Access to Pharmacy Kate,
- 1:05Speaker 3: and it's so good to see.
- 1:06Speaker 4: You, hey, Todd. It's always nice to be with you guys.
- 1:09Speaker 3: All right, So, you know, specially pharmacy. That was something
- 1:13Speaker 3: that I struggled with. I came out of long term
- 1:15Speaker 3: care pharmacy, started working in software systems that would combine
- 1:19Speaker 3: a long term care setting in our community setting and
- 1:22Speaker 3: how they were managing the facility versus the individual patient.
- 1:27Speaker 3: And then all of a sudden, I started learning about
- 1:29Speaker 3: workflow in the specialty sector. Something special about What was
- 1:34Speaker 3: micromerciant transforming into Primarx is the fact that your organization
- 1:40Speaker 3: has centered on community, long term care, compounding, and now
- 1:44Speaker 3: of course specialty has all been a part of how
- 1:47Speaker 3: important it is to an organization that focuses on specialty
- 1:50Speaker 3: pharmacy to kind of manage their business. Talk to me
- 1:53Speaker 3: about Primarx. Why are you guys here at Assembia twenty
- 1:56Speaker 3: twenty five.
- 1:57Speaker 4: So, Todd, I think you will said a lot of
- 2:00Speaker 4: things that sort of resonated with us. We've been focused
- 2:04Speaker 4: on helping pharmacist period and pharmacists all they do is
- 2:08Speaker 4: dispense drugs, you know, obviously the clinical intervention, and that's
- 2:12Speaker 4: how we started in the business. But as the business
- 2:14Speaker 4: of pharmacy changed, we realized that we needed to change
- 2:17Speaker 4: and that's the reason why we went into long term
- 2:20Speaker 4: care pharmacies, physicians offices, mail orders, and obviously the specialty pharmacy.
- 2:27Speaker 4: And believe, it's not something a cookie cut resolution, it's
- 2:30Speaker 4: something that means different for every pharmacy. The reason is
- 2:34Speaker 4: because in the business of specialty medications, you are not
- 2:37Speaker 4: just dealing with the patient. You are dealing with the
- 2:39Speaker 4: patient and obviously there's a lot of information that needs
- 2:43Speaker 4: to be captured that goes beyond a standard pharmacy management system.
- 2:47Speaker 4: So there may be scenarios where a pharmacies maintaining one
- 2:52Speaker 4: particular disease state and has expertise in that and also
- 2:55Speaker 4: has an option to go through URAQ and JCO and
- 2:58Speaker 4: ACIS and get a seat at the That doesn't mean
- 3:01Speaker 4: that just because they have a seat at the table
- 3:03Speaker 4: and there you recocredate it, they may get the job done.
- 3:07Speaker 4: So what it requires in order for you to get
- 3:09Speaker 4: the job and is access to the different elements that
- 3:15Speaker 4: surround the patient. Give them access to the data as
- 3:18Speaker 4: an unrequired in a secure manner, and the ability to
- 3:23Speaker 4: board a patient or through an intake and ask relevant
- 3:27Speaker 4: questions about that particular disease state is extremely important. Before dispensing.
- 3:32Speaker 4: There are checklists that a pharmacy needs to do. Post dispensing,
- 3:35Speaker 4: there are items that the pharmacy needs to capture, and
- 3:38Speaker 4: then all this information needs to be made available to physicians.
- 3:43Speaker 4: There are manufacturers that are involved in the here and
- 3:47Speaker 4: there's a lot of that kind of handshaking happening across
- 3:50Speaker 4: the different elements. Right, So we started off from a
- 3:54Speaker 4: clinical assessment portion where we ask the pharmacy, hey, how
- 3:58Speaker 4: do you want to handle these questions? And every single
- 4:01Speaker 4: pharmacy had a different answer. The way that a clinical
- 4:04Speaker 4: pharmacist operates and things about a particular disease state is
- 4:08Speaker 4: very unique to that particular organization. So we knew that
- 4:10Speaker 4: a cookie cutural solution would not work, which is why
- 4:13Speaker 4: we went into clinical assessments and gave them the ability
- 4:15Speaker 4: to create their own questions about disease states, have assessments completed,
- 4:21Speaker 4: have welcome packages, communication with the patient, you know, with
- 4:24Speaker 4: the text messaging or the phone call, that needed to
- 4:26Speaker 4: be captured. All the different touchpoints that happen in a
- 4:29Speaker 4: specialty medication dispensing, they needed to be captured and reported on.
- 4:33Speaker 4: And that's where the complexity grew. And we realized that
- 4:35Speaker 4: this is not something that can be done with a
- 4:38Speaker 4: standard pharmacy management system. So we just kept on evolving
- 4:41Speaker 4: our software and had the web portals so that were
- 4:44Speaker 4: the sales reps and the physicians can get access to data,
- 4:48Speaker 4: have data being reported to manufacturers, and so on and
- 4:51Speaker 4: so forth. Right, I mean, just the fact that I
- 4:54Speaker 4: haven't paused for the last three minutes, even for five seconds,
- 4:59Speaker 4: that means there's a lot and do here.
- 5:02Speaker 3: But the reason why I want our listeners to understand
- 5:04Speaker 3: this is Primary X is unique that you're not buying
- 5:08Speaker 3: multiple platforms in order to hone in on the very
- 5:12Speaker 3: specific way that your operation has to run, based on
- 5:15Speaker 3: the fact that specially pharmacy is much different and has
- 5:18Speaker 3: more criteria to disease state management and reimbursement and coordination
- 5:23Speaker 3: of care than a community pharmacy that's filling an antibiotic.
- 5:27Speaker 3: And those are two environments. It's like high prescription volume
- 5:31Speaker 3: versus lower prescription volume, but the lower prescription volume requires
- 5:35Speaker 3: disease state management tracking and data collection and REMS reporting
- 5:40Speaker 3: and like all of this specific things. And what's unique
- 5:43Speaker 3: about Primary X is you've designed this all out of
- 5:46Speaker 3: a platform that has evolved in multiple ways where you're
- 5:50Speaker 3: able to deliver long term care, speceissivity, community, and now
- 5:54Speaker 3: of course specialty.
- 5:55Speaker 4: Yeah. Absolutely, And you know you mentioned a variety of
- 5:58Speaker 4: things as patient says ssistance program that needs to go through,
- 6:01Speaker 4: and then the size and operations of pharmacies. We have
- 6:04Speaker 4: had organizations that have call centers that basically work with
- 6:08Speaker 4: those pharmacies, and those call center personnel live in their CRM.
- 6:12Speaker 4: So we actually developed Primarx as a service middle layer
- 6:17Speaker 4: that stays between the CRM and the actual pharmacy management system,
- 6:21Speaker 4: and the personnel from CRM or the call center people
- 6:25Speaker 4: can actually help the patient in saying that, hey, we
- 6:29Speaker 4: can do your eligibility once the copey appear, as hey
- 6:33Speaker 4: can you afford this? If not, then we can go
- 6:35Speaker 4: through a patient assistance program. If there's a rejection, they
- 6:39Speaker 4: are able to like, hey there's a prior authorization. Let
- 6:42Speaker 4: me work this angle for you, whether go through cover
- 6:45Speaker 4: my Minds or so many other different integrations. But that's
- 6:48Speaker 4: where the scope of this practice is, right. It's not
- 6:52Speaker 4: just filling up prescription and dispensing it. There's so many
- 6:54Speaker 4: different things that go beyond between them.
- 6:57Speaker 3: All Right, I'm excited about something. I'm announcing it. This
- 6:59Speaker 3: is the first time at Pharmacy Podcast Network has talked
- 7:02Speaker 3: about it, and Caiden doesn't even know I'm about to
- 7:04Speaker 3: say this, But we have a celebration happening later this year.
- 7:08Speaker 3: That's the annual, the first inaugural prime rx user group
- 7:14Speaker 3: conference called Explore. So talk to our listeners about that event.
- 7:19Speaker 4: Oh yeah, we are super excited about this particular event.
- 7:22Speaker 4: This is the first time in a little bit over
- 7:25Speaker 4: thirty years that we are actually creating our own user
- 7:27Speaker 4: group meeting. We have an awesome group of users that
- 7:31Speaker 4: have been supporting us and have been using our platform
- 7:34Speaker 4: for so many years, and this is a chance to
- 7:37Speaker 4: get all of them together into a room, bring in
- 7:39Speaker 4: special speakers, also give them a little bit of glimpse
- 7:43Speaker 4: into what we are doing with AI, what kind of
- 7:46Speaker 4: platforms we're building. You know, how do we do automation. Yes,
- 7:49Speaker 4: sure there's like five different ways to do a refil,
- 7:52Speaker 4: but what does data show? What are the best practices
- 7:54Speaker 4: to manage a pharmacy. How can you reduce your reliance
- 7:59Speaker 4: on technicians and put the instead of putting them behind
- 8:01Speaker 4: the computer, How can you take them in front of pharmacies,
- 8:05Speaker 4: show them that if you're opening a pharmacy, is it
- 8:07Speaker 4: possible to literally like open pharmacy where there is less
- 8:11Speaker 4: touch points and there is more consultations and you know,
- 8:15Speaker 4: just talk about more about will be talk about delivery systems,
- 8:18Speaker 4: you know, how do you make sure that what is
- 8:20Speaker 4: the best way to optimize her out get the prescriptions
- 8:24Speaker 4: there delivered fast? How do you divide your territories into zones,
- 8:28Speaker 4: how do you print your shipping, and like a whole
- 8:30Speaker 4: variety of things. The practice of pharmacy has literally changed
- 8:33Speaker 4: in front of our eyes over the last three decades,
- 8:36Speaker 4: and we feel like this is the perfect time to
- 8:37Speaker 4: bring all our users together, give them a chance to
- 8:41Speaker 4: speak with each other, see what works in one pharmacy
- 8:43Speaker 4: versus another, and for us to bring in a variety
- 8:46Speaker 4: of speakers so that way they can learn.
- 8:47Speaker 5: From the best.
- 8:48Speaker 3: I'm excited you're going to hear more about this event
- 8:50Speaker 3: on the Pharmacy Podcast Network. We're going to be bringing
- 8:53Speaker 3: Caiton and some of his team members and actually some
- 8:56Speaker 3: of his pay is clients. I say, patients, it's your
- 9:00Speaker 3: pharmacies out there using it to talk about the upcoming conference.
- 9:03Speaker 3: Go to primearx dot io once again, prime rx dot io,
- 9:10Speaker 3: thank you so much for making time for us here
- 9:12Speaker 3: Kitin at at the Access twenty five Access to Pharmacy Conference.
- 9:16Speaker 4: Absolutely, it's always a pleasure to be with you, and
- 9:19Speaker 4: I'm super stoked about the fact that you know, the
- 9:21Speaker 4: listeners are getting to get a chance to see a
- 9:24Speaker 4: complete different variety of speakers on your platform than Absolutely.
- 9:27Speaker 6: Thank you.
- 9:33Speaker 3: Access to Pharmacy or actually say, Access to Specialty Pharmacy.
- 9:37Speaker 3: We're here at Assembia twenty twenty five with Joe Dipinto. It
- 9:41Speaker 3: is so good to see you, I said as you walked.
- 9:43Speaker 6: Up to the booth. Last time I saw you was
- 9:45Speaker 6: last year.
- 9:46Speaker 7: Great to see you again, Todd.
- 9:48Speaker 6: It's nice to see you as well.
- 9:49Speaker 3: So you taught me some things last year during the
- 9:53Speaker 3: twenty twenty four Access to Pharmacy and that was where
- 9:57Speaker 3: we are with gene cell therapy. I can't believe it's
- 10:01Speaker 3: been twelve months, but so much has happened. I really
- 10:05Speaker 3: want you to give our listeners an update from A
- 10:07Speaker 3: Kessen's perspective. Introduce yourself and let us know what is
- 10:11Speaker 3: going on in gene cell therapy.
- 10:13Speaker 7: Yeah, Todd, so thanks again for having me. It's great
- 10:16Speaker 7: to come back. Twelve months have gone quickly, and the
- 10:20Speaker 7: space continues to evolve in sell in gene therapy and
- 10:24Speaker 7: a lot of exciting news approvals progress in the evolution both.
- 10:29Speaker 6: Clinically and commercially.
- 10:32Speaker 7: And the great news is more patients getting access to
- 10:35Speaker 7: sell in gene therapy. Groundbreaking science and we need to
- 10:39Speaker 7: make sure that that continues to accelerate. And that's why
- 10:42Speaker 7: we're here to make sure that that continues.
- 10:45Speaker 3: Give us an example of what disease state comes to
- 10:48Speaker 3: first in mind where this is having the most success.
- 10:52Speaker 7: Well, whenever you think of sell in gene therapy, I
- 10:55Speaker 7: think everybody really moves to hematology, right, That's where the
- 10:59Speaker 7: jumping off point was. That's where many of the products
- 11:03Speaker 7: that initially launched were in late stage hematologic malignancies and
- 11:08Speaker 7: even non hematologic maligencies. The excitement is pipelines are full
- 11:13Speaker 7: in pharma of non hematologic malignancies, non hematology areas like
- 11:19Speaker 7: autoimmune disease, cardiovascular disease, neurology, really big patient populations, which
- 11:27Speaker 7: is really exciting for patients and for biopharma as the
- 11:32Speaker 7: science continues to evolve clinically and eventually we'll launch into
- 11:36Speaker 7: the commercial space.
- 11:37Speaker 3: When I think of the relationship between the pharmacists, the physician,
- 11:41Speaker 3: our quarterback of the healthcare plan, the patient the most
- 11:44Speaker 3: important part in the entire thing. I think of how
- 11:48Speaker 3: pharmacists can make some adjustments during therapy, maybe during a
- 11:53Speaker 3: titration time, or adding something to their therapy to make
- 11:56Speaker 3: them feel better if they are experiencing some nausea or
- 12:00Speaker 3: something like that. When I think of gene cell therapy.
- 12:03Speaker 3: When does the pharmacist step in and start talking with
- 12:06Speaker 3: the physician and the family and the patient to say, hey,
- 12:09Speaker 3: this could be a really good option.
- 12:11Speaker 7: The pharmacist is a critical component of the treatment team
- 12:15Speaker 7: for sealing gene therapy. Remember, predominantly what we've seen in
- 12:19Speaker 7: early phases of selling gene therapies, it's being done at
- 12:22Speaker 7: academic medical centers. The good news in the last twelve
- 12:25Speaker 7: to eighteen months, we've seen an expansion to community and
- 12:29Speaker 7: pharmacy will play a role both in academic center and
- 12:32Speaker 7: the community as patients continue to get both commercial and
- 12:36Speaker 7: clinical selling gene therapy. But a critical component of the
- 12:40Speaker 7: treatment team, the pharmacist plays absolutely.
- 12:43Speaker 3: So, what are some of the challenges that you're seeing
- 12:45Speaker 3: where gene cell therapy is starting to lessen the log
- 12:50Speaker 3: jam that always happens within the world of rare disease
- 12:53Speaker 3: and specialty pharmacy.
- 12:55Speaker 5: Yeah.
- 12:55Speaker 7: So, you know, in the last twelve months since we
- 12:59Speaker 7: last talked, I'll say that we've seen a continued trend
- 13:03Speaker 7: towards moving selling gene therapy more towards community, both community
- 13:08Speaker 7: hospitals and even some community clinics.
- 13:11Speaker 6: And what's occurring.
- 13:13Speaker 7: Is more and more of those community hospitals are looking
- 13:16Speaker 7: at alternatives. A they can buy and build the product,
- 13:20Speaker 7: they can bring the product in. B they can use
- 13:22Speaker 7: specialty pharmacy to wipe bag these products. And we're seeing
- 13:26Speaker 7: more and more optionality being explored by these community hospitals
- 13:32Speaker 7: for variety reasons. And that's the great thing about being
- 13:35Speaker 7: here at ASSEMBIA. It's a who's who of specialty pharmacy.
- 13:38Speaker 3: So McKesson has an intimate relationship with the pharmacy markets.
- 13:43Speaker 6: They're all over the place.
- 13:45Speaker 3: They have the technology platforms, they obviously have the wholesale division.
- 13:49Speaker 3: The trust that you've built with the community pharmacies, the
- 13:52Speaker 3: trust that's been built with our senior care pharmacy consultants.
- 13:57Speaker 6: This is very important.
- 13:58Speaker 3: So when I think of gene and cell therapy as
- 14:00Speaker 3: a question mark in the patient's mind, I look to
- 14:03Speaker 3: the pharmacists to start clarifying and building additional trust. Talk
- 14:06Speaker 3: to us about that element and the uniqueness that McKesson
- 14:09Speaker 3: brings to this market.
- 14:11Speaker 7: So last year in the fall, we branded our celling
- 14:16Speaker 7: gene vertical at McKesson and we called it in Spirogene.
- 14:19Speaker 6: That's the name of the vertical that.
- 14:20Speaker 7: Really focuses at McKesson primarily on cell gene advanced therapies,
- 14:26Speaker 7: and we took that trust from the McKesson brand and
- 14:29Speaker 7: we expanded it out with the specialty around all things
- 14:33Speaker 7: sell in gene therapy floating through in spirogene. There's a
- 14:38Speaker 7: lot of trust being built there from a standpoint of
- 14:41Speaker 7: all these services, whether there's solutions, technology, are specific for
- 14:45Speaker 7: selling gene therapy, and the pharmacist plays a critical component
- 14:48Speaker 7: of that. The specialty pharmacies part of our offering as
- 14:52Speaker 7: well as our standard distribution, patient logistics, and patient access.
- 14:58Speaker 3: So what challenges are you seeing in place that you think, hey,
- 15:01Speaker 3: this is a perfect opportunity for us to expand gene
- 15:05Speaker 3: and cell therapy into the treatment programs.
- 15:08Speaker 7: So you know, when you think about the explosive growth
- 15:14Speaker 7: in healthcare and you think about the exciting spaces, they're
- 15:17Speaker 7: typically driven by strong clinical data. Selling gene therapy has
- 15:23Speaker 7: really strong clinical data and it's in areas of high
- 15:27Speaker 7: unmet medical need. So that's an exciting phase. But how
- 15:31Speaker 7: do you take this really complex science and scale it
- 15:36Speaker 7: and bring it to the masses in a consistent fashion
- 15:39Speaker 7: when they all act a little differently. Cell therapies act
- 15:43Speaker 7: differently than gene therapies, right, And what we do at
- 15:46Speaker 7: inspiro Gene is we help the ecosystem as an ally
- 15:51Speaker 7: solution for that complexity, so that way the healthcare professionals,
- 15:56Speaker 7: whether they're clinicians or pharmacists, can have a streamlined, democrat tized,
- 16:00Speaker 7: industrialize whatever adjective you want to put in there. That
- 16:03Speaker 7: really talks about consistent utilization of a product, which is
- 16:07Speaker 7: really critical so that the right product gets to the
- 16:09Speaker 7: right patient at the right time. And you know, we
- 16:12Speaker 7: do this always for the patient and those patients benefit
- 16:15Speaker 7: from that significantly.
- 16:17Speaker 3: All Right, lots of specially pharmacists listening right now, lots
- 16:20Speaker 3: of people in the space. What's the best way to
- 16:23Speaker 3: reach out and get a hold of you.
- 16:24Speaker 7: Joe, So you can always get a hold of me
- 16:27Speaker 7: at inspirogene dot com. It's our website where the specialty
- 16:31Speaker 7: pharmacist will find resources, both clinical resources, commercial resources, latest
- 16:38Speaker 7: news on selling gene therapy and some of our solutions
- 16:42Speaker 7: and some of the technology that we've been developing in
- 16:45Speaker 7: the last twelve months to really help navigate the value chain.
- 16:49Speaker 3: You're also on LinkedIn, so absolutely on LinkedIn. Reach out
- 16:52Speaker 3: to Joe Dipinto at McKesson Specialty Pharmacy Services on LinkedIn
- 16:58Speaker 3: at the website. Look down on the show notes you'll
- 17:00Speaker 3: see the link right there to the landing page that
- 17:03Speaker 3: Joe mentioned.
- 17:04Speaker 6: Joe, thanks so much for being part of this.
- 17:06Speaker 7: Okay, buddy, thank you guys.
- 17:10Speaker 8: Hi, this is Heather Bonome, director of Pharmacy with URAK
- 17:14Speaker 8: and you were listening to the Pharmacy Podcast.
- 17:23Speaker 3: Heather at Access twenty twenty five at s MBIA twenty
- 17:27Speaker 3: twenty five.
- 17:27Speaker 6: It's so good to.
- 17:28Speaker 1: See you you as well, great to be here.
- 17:31Speaker 3: Not the first time you've been on the Pharmacy Podcast.
- 17:33Speaker 3: We've talked to you a couple times actually, And the
- 17:37Speaker 3: importance of your IRAQ, the importance of keeping up with
- 17:39Speaker 3: what's happening in the profession accreditation, how important that is
- 17:43Speaker 3: to us as an organization and profession. And we're here
- 17:46Speaker 3: at Specialty Pharmacy focus, so right out of the gate,
- 17:50Speaker 3: we need to get into this. And how is your
- 17:52Speaker 3: rack tied into specialty? Oh?
- 17:55Speaker 8: Absolutely, Pharmacy is a core part of our accreditation. We
- 17:59Speaker 8: have credit across the healthcare landscape, but I oversee the
- 18:03Speaker 8: pharmacy on portfolio and really ninety percent of the reviews
- 18:08Speaker 8: that my team does, my team of pharmacists do, are
- 18:12Speaker 8: in the specialty pharmacy space.
- 18:13Speaker 1: It's critical to the industry.
- 18:15Speaker 8: It's really setting the standards and pharmacies that are accredited
- 18:20Speaker 8: for specialty pharmacy. It's really what defines them as a
- 18:23Speaker 8: specialty pharmacy.
- 18:25Speaker 3: When I think of a manufacturer who has a specific
- 18:28Speaker 3: complex medication, it's sensitive, it's timely, having to get the
- 18:33Speaker 3: patient on it as quickly as possible.
- 18:36Speaker 6: They have standards.
- 18:38Speaker 3: Where do the standards to build accreditating accredited specialty pharmacies?
- 18:44Speaker 6: Where does it start?
- 18:45Speaker 8: Yeah, So all of our standards really come from the industry.
- 18:51Speaker 8: We have advisory groups that are made up of industry
- 18:56Speaker 8: experts and we have a couple We've got standing advisory
- 18:58Speaker 8: groups that we can go to all the time, and
- 19:00Speaker 8: then when we're creating a new program or when we're
- 19:03Speaker 8: revising a program, we'll stand up ad hoc groups. In fact,
- 19:06Speaker 8: right now we are revising our specialty pharmacy standards and
- 19:11Speaker 8: we have put some standards out for comment, and based
- 19:15Speaker 8: on that comment, we are now reviewing with this special
- 19:19Speaker 8: special Specialty Advisory Group some ideas that we have for
- 19:24Speaker 8: updates to the standards, and so we pose that to
- 19:27Speaker 8: them and we post sessions where we get feedback, live feedback,
- 19:32Speaker 8: more written feedback.
- 19:33Speaker 1: It's great.
- 19:34Speaker 8: We do a series of those meetings and then in fact,
- 19:37Speaker 8: we did a pre ASSEMBIA conference on Sunday afternoon where
- 19:43Speaker 8: we invited current accredited organizations to come in and we
- 19:48Speaker 8: did some education, and then we spent the back half
- 19:51Speaker 8: of that meeting and it was a whole afternoon getting feedback, Hey,
- 19:55Speaker 8: if we update it to this, is this realistic? Is
- 19:57Speaker 8: this really best practice? What would the impact to your organization?
- 20:03Speaker 8: What else would you like to see? So it was
- 20:05Speaker 8: a really great interactive session where we're hearing directly from
- 20:11Speaker 8: the industry what these standards need to be, what should
- 20:14Speaker 8: we change, what shouldn't we change? And it is just
- 20:17Speaker 8: a really great opportunity and we can do that because
- 20:21Speaker 8: all of specialty pharmacy is here, a lot of specialty
- 20:24Speaker 8: pharmacy is represented here, and it's just this great opportunity
- 20:27Speaker 8: for us to bring everyone together to have that conversation.
- 20:30Speaker 3: Heather talked to me about timing. I think of if
- 20:33Speaker 3: I take my driver's license, it expires. I think in Pennsylvania,
- 20:38Speaker 3: I think it's five years. So is there a realm
- 20:42Speaker 3: of I'm a certified Iraq specialty pharmacy. Is there a
- 20:46Speaker 3: cycle of time that I have to be re certified?
- 20:49Speaker 8: Yeah, So our accreditation programs are all based on a
- 20:51Speaker 8: three year cycle. Okay, So you get accredited and you
- 20:54Speaker 8: need to maintain compliance with all the standards throughout those
- 20:56Speaker 8: three years and then about six months prior to you expiring,
- 21:01Speaker 8: that's when we really start the work of the reaccreditation process.
- 21:05Speaker 8: And so then you go through the accreditation process again,
- 21:08Speaker 8: you know, having the knowledge of the standards, but then
- 21:10Speaker 8: also complying with any new updates and things like that.
- 21:14Speaker 8: But every three years we get to go through the
- 21:16Speaker 8: review process with our with our accredited pharmacies.
- 21:19Speaker 3: From a EURACT perspective of understanding the pitfalls of not
- 21:23Speaker 3: having the accreditation, what problems that that could cause. Do
- 21:26Speaker 3: you have any like mock audits that are ever happening
- 21:29Speaker 3: with any of your accredited pharmacies where you're either giving
- 21:32Speaker 3: them a guidance as to where to go to get
- 21:36Speaker 3: a pretend audit done or you doing it yourself.
- 21:39Speaker 1: Yeah, So we don't do mock audits ourselves. We do
- 21:42Speaker 1: a lot of education.
- 21:44Speaker 8: So as an accrediting organization. We we review, we survey.
- 21:50Speaker 8: We as an accredited organization, and other accrediting organizations have
- 21:53Speaker 8: done different things.
- 21:53Speaker 1: We've made a decision not.
- 21:54Speaker 8: To consult really, but we focus a lot on education,
- 21:58Speaker 8: so we do meetings like here because we did some
- 22:02Speaker 8: education as well. We have a whole client information hub
- 22:06Speaker 8: where we have standards, webinars, we have hey tips on
- 22:09Speaker 8: the process webinars, we hold live webinars for our clients.
- 22:13Speaker 1: So we do a lot of education to help to
- 22:14Speaker 1: get them prepared.
- 22:16Speaker 8: The audit question is a really good one because we
- 22:19Speaker 8: do suggest that organizations audit their files, audit your patient
- 22:23Speaker 8: management files, audit your HR records, just to make sure
- 22:26Speaker 8: you're going to have everything in advance.
- 22:28Speaker 1: And some organizations have figured out really good ways to
- 22:30Speaker 1: do that themselves.
- 22:32Speaker 8: And certainly there are many consultants, like accreditation consultants in
- 22:36Speaker 8: the industry that help organizations get accredited, and they have
- 22:41Speaker 8: their own bock survey tools that can be really helpful
- 22:44Speaker 8: to get help in the organization get ready for.
- 22:46Speaker 1: Just even to know what to expect when we're going to.
- 22:49Speaker 6: Do our review.
- 22:50Speaker 3: We're here at a SMBA, obviously, but your ac is
- 22:53Speaker 3: all over the place. You're in every you know, so
- 22:55Speaker 3: many facets of the profession. Talk to us about the
- 22:57Speaker 3: expansion of your IRAQ in other set of pharmacy.
- 23:00Speaker 8: Yeah, no, you're absolutely right. I mean we started with
- 23:02Speaker 8: utilization review and health plan and cause management, disease management,
- 23:05Speaker 8: so we do all of that. Then you know, the
- 23:07Speaker 8: pharmacy is my whole world, and we're doing a lot
- 23:10Speaker 8: of really exciting things there and then you know, other
- 23:13Speaker 8: things around maybe a few years ago, we launched our
- 23:18Speaker 8: Health Equity accreditation, which any healthcare organization can pursue and achieve,
- 23:24Speaker 8: and actually here at Ascembia, our CEO, doctor Sean Griffin,
- 23:28Speaker 8: was on stage with CBS Pharmacy, who was the first
- 23:31Speaker 8: organization to achieve that accreditation.
- 23:34Speaker 1: Really exciting.
- 23:35Speaker 8: It was a great conversation just because you know, I
- 23:38Speaker 8: think we stood up the program for the right reasons
- 23:40Speaker 8: and they sought.
- 23:41Speaker 1: And achieved the accreditation for the right reason.
- 23:43Speaker 8: So that was really exciting, and we're seeing a lot
- 23:45Speaker 8: more interest in that health equity space. Something else that
- 23:49Speaker 8: we're just getting ready to launch is a Healthcare AI accreditation.
- 23:54Speaker 3: All right, you're ruined my next question because I was
- 23:56Speaker 3: going to say, what's the impact of AI on accreditation.
- 24:00Speaker 6: So there you're stole my thunder.
- 24:01Speaker 1: Yeah, so you know.
- 24:03Speaker 8: Something that we're really excited about, and we put out
- 24:08Speaker 8: a call for participants in an advisory group to participate
- 24:11Speaker 8: in that. We've got some really, we've got a ton
- 24:13Speaker 8: of interest. We couldn't include everybody.
- 24:15Speaker 1: We got so much interest.
- 24:16Speaker 8: Some very big players in the industry, both from tech
- 24:20Speaker 8: as well as from healthcare are going to be part
- 24:22Speaker 8: of that and we're going to be launching those So
- 24:24Speaker 8: that program is going to be stood up and also
- 24:26Speaker 8: launched later this year.
- 24:27Speaker 1: So really exciting.
- 24:29Speaker 3: You have to come back on this Week in Pharmacy
- 24:31Speaker 3: and talk to us about that specifically. So you're going
- 24:34Speaker 3: to get an email from me as.
- 24:35Speaker 6: A follow up. I like it.
- 24:36Speaker 1: I'd be happy to.
- 24:37Speaker 6: Thank you, Heather.
- 24:38Speaker 3: This is so special to be able to be with
- 24:40Speaker 3: you here at ACEMBIA Assembia twenty twenty five. We hope
- 24:43Speaker 3: to interview you at twenty twenty six.
- 24:46Speaker 1: This sounds great. I'll be there.
- 24:51Speaker 9: Hi. This is Jill Pelier from a Specia and you
- 24:56Speaker 9: are listening to the Pharmacy podcast.
- 24:57Speaker 3: Network show Access to Pharmacy twenty twenty five. What an
- 25:07Speaker 3: exciting time to be together. I like to say together
- 25:09Speaker 3: our ex how are you good?
- 25:12Speaker 9: How are you? It's so nice to meet you in person.
- 25:14Speaker 3: Yes, it's funny how LinkedIn is really my first bridge
- 25:20Speaker 3: to building contacts, and I've connected with more pharmacy professionals
- 25:26Speaker 3: in my twenty two years in healthcare through LinkedIn than
- 25:29Speaker 3: I think any other platform.
- 25:30Speaker 6: What about you, what platform do you use?
- 25:32Speaker 9: Definitely LinkedIn. I love connecting with people on there. I
- 25:37Speaker 9: love seeing what everyone's doing, especially people in non traditional
- 25:41Speaker 9: career paths, entrepreneurs, anyone in specialty pharmacy. We can nerd
- 25:46Speaker 9: out about the same thing.
- 25:47Speaker 3: So exactly, nerd out, it's the right way to say it.
- 25:50Speaker 3: So we're nerding out now on specialty pharmacy specifically, tell
- 25:55Speaker 3: our listeners what your organization is doing, how you're connecting
- 25:59Speaker 3: into specially.
- 26:00Speaker 6: Yeah.
- 26:01Speaker 9: So I've been working in specialty pharmacy since two thousand
- 26:03Speaker 9: and seven, so quite a while. And right now I'm
- 26:06Speaker 9: working with a Specia it's special without the L and
- 26:11Speaker 9: we write specialty pharmacy disease specific workflows. So basically what
- 26:15Speaker 9: that means is that specialty pharmacies need to have workflows
- 26:19Speaker 9: by accreditations like UREK ANDAHC, and the workflows will guide
- 26:23Speaker 9: the pharmacists through the initial assessment process, education and counseling
- 26:27Speaker 9: for the patient, and the reassessment process. And they have
- 26:30Speaker 9: to hit all these certain points for those assessments and
- 26:33Speaker 9: counseling that's required by accreditation, and they need to have
- 26:36Speaker 9: a workflow that guides them through those assessment activities that
- 26:40Speaker 9: are disease specific for all the different conditions that they treat.
- 26:43Speaker 9: And so we write the content for those workflows that
- 26:46Speaker 9: pharmacies can implement into their existing software platform. Rather than
- 26:51Speaker 9: creating that content by themselves and updating and maintaining it,
- 26:54Speaker 9: we provide the content for them to use while they
- 26:57Speaker 9: implement the program themselves.
- 26:59Speaker 3: All right, So now you're starting to flick on the
- 27:03Speaker 3: lights in my head based on I know exactly kind
- 27:06Speaker 3: of what you're dialing into. So back in the day,
- 27:08Speaker 3: back in the d in two thousand and four, I
- 27:11Speaker 3: worked for the first sequel based pharmacy management system that
- 27:14Speaker 3: was dedicated to institutional long term care pharmacy. Shout out
- 27:17Speaker 3: to Framework LTC and they concentrated just on that space,
- 27:22Speaker 3: and then all of a sudden they would start adding
- 27:24Speaker 3: in as the years progressed, ways to manage bed sorece
- 27:28Speaker 3: situations or best practices for this medication or some of
- 27:32Speaker 3: the warnings that are tied into this like a whole track.
- 27:35Speaker 3: So then when I get into specialty, because Assembia before
- 27:39Speaker 3: it was a Sembia, it was Armada Health And what
- 27:42Speaker 3: an amazing organization, What an amazing time that we're here.
- 27:45Speaker 3: Now this is my favorite business conference and specialty. But
- 27:48Speaker 3: when I was in specialty pharmacy, we had theragy ASEMBIA
- 27:53Speaker 3: one key centrics where they were building workflow that was
- 27:58Speaker 3: matching conditions and z states and REMS reporting and other
- 28:02Speaker 3: things that were very specific to the condition and the
- 28:05Speaker 3: NDC and the specialty met So expand upon that, and
- 28:08Speaker 3: let's talk about jettison that I stop selling pharmacy software
- 28:13Speaker 3: in what twenty twelve or something.
- 28:16Speaker 6: So a lot's happened since.
- 28:17Speaker 3: The API world that messed everything up all the time.
- 28:20Speaker 3: But tell us about how you're fitting into that ecosystem.
- 28:23Speaker 9: Yeah, that's a great question. So there are definitely some
- 28:26Speaker 9: great software solutions out there right now. You mentioned Thera
- 28:29Speaker 9: GESMBA one. Those are some of the popular ones that
- 28:32Speaker 9: it's a software solution that has these workflows and clinical
- 28:35Speaker 9: content in the workflows already. However, some pharmacies want to
- 28:40Speaker 9: use whatever software system they already have, so if they
- 28:42Speaker 9: have a pharmacy dispensing system, if they have an electronic
- 28:45Speaker 9: health record, they would rather document in their current system. However,
- 28:49Speaker 9: that means they have to develop all the content and
- 28:50Speaker 9: the workflows, making sure they're clinically robust, not too much
- 28:53Speaker 9: information that it's overwhelming, we don't want to drop the
- 28:55Speaker 9: whole package insert in there, and also not too little
- 28:58Speaker 9: information that it's not helped for their pharmacists on a
- 29:01Speaker 9: day to day basis. So they have to develop clinical
- 29:03Speaker 9: content for each of these disease states, and then they
- 29:05Speaker 9: also need to make sure that the workflows are going
- 29:07Speaker 9: to be supporting accreditations and making sure that they're hitting
- 29:11Speaker 9: all the boxes that they need to hit to be
- 29:14Speaker 9: compliant with accreditation. So instead of pharmacies recreating the wheel
- 29:17Speaker 9: and each creating their own workflows, we just develop the content.
- 29:20Speaker 9: So we're a little bit in between the software solutions
- 29:22Speaker 9: that have everything software plus the content and the pharmacies
- 29:26Speaker 9: that choose to develop their own workflows in their existing
- 29:28Speaker 9: platform and they create the content. So we're kind of
- 29:31Speaker 9: in the middle creating the content that they can implement
- 29:33Speaker 9: into their own system.
- 29:34Speaker 3: So I see so many evolving community pharmacies that either
- 29:40Speaker 3: get into compounding or specialty pharmacy, long term care, additional
- 29:47Speaker 3: business steps. I could see a well versed organization like
- 29:51Speaker 3: a shout out to Chris Antipas and Pittsburgh who has
- 29:54Speaker 3: a specialty pharmacy, and I'm going to tell them about you,
- 29:57Speaker 3: and he wants to build a custom system internal to
- 30:02Speaker 3: the way that they do business, the payers that they're
- 30:04Speaker 3: in touch with, pharmacogenomics information, things that some of the
- 30:08Speaker 3: systems just don't match up. So when you think of
- 30:11Speaker 3: these custom organizations, I think of JB Consulting, who's on
- 30:15Speaker 3: our board of advisor.
- 30:16Speaker 6: Shout out to Sean Jensen.
- 30:17Speaker 3: He helps to kind of marry these systems together and
- 30:20Speaker 3: then be able to take workflow, remote patient monitoring, adherence
- 30:25Speaker 3: systems and then your deep dive understanding of a specific
- 30:31Speaker 3: disease state and the medication and kind of best protocols.
- 30:34Speaker 6: I love it.
- 30:35Speaker 9: Yeah, yeah, So ours is great for pharmacies that want
- 30:37Speaker 9: to develop their own custom platform in their own system
- 30:41Speaker 9: or even develop their unique software, because we provide the
- 30:45Speaker 9: content that will give them a starting place for making
- 30:47Speaker 9: sure that they're clinically sound, they are written by specialty
- 30:50Speaker 9: clinical pharmacists and peer reviewed by practicing specialty clinical pharmacists,
- 30:55Speaker 9: and also making sure it's meeting the accreditation standard. So
- 30:58Speaker 9: that's the basic backbone of what they need. But then
- 31:00Speaker 9: they may want to customize them as well for payer requirements,
- 31:03Speaker 9: manufacturer requirements, et cetera. And so they still need the
- 31:07Speaker 9: content to put into their existing system. So our workflows
- 31:11Speaker 9: are a great place to start and certainly can be
- 31:13Speaker 9: developed further to meet specific pharmacy needs and preferences.
- 31:18Speaker 3: All right, specially pharmacists, especially pharmacies, directors, operations. People are
- 31:23Speaker 3: listening right now and you've piqued their interest. How do
- 31:26Speaker 3: they reach out to you?
- 31:27Speaker 9: Well, I'm on LinkedIn, very easy to find. I think
- 31:31Speaker 9: I have a unique name.
- 31:32Speaker 1: It's Jill Pellier P A S l I E R.
- 31:35Speaker 9: Otherwise it's you can check us out on the website
- 31:38Speaker 9: at Specia rx dot com, so it's special without the
- 31:41Speaker 9: l Specia rx dot com.
- 31:43Speaker 6: That's awesome.
- 31:44Speaker 3: Thank you for being part of Access to twenty twenty
- 31:47Speaker 3: five here in Vegas, Assembia.
- 31:49Speaker 6: This was special. Thanks for doing this.
- 31:51Speaker 9: Yeah, my pleasure. So nice to talk to you today.
- 31:57Speaker 3: One of the podcasts hosts of Marketing Vitals, Nicole mcclaur
- 32:00Speaker 3: is here with me at Access twenty five Access to
- 32:03Speaker 3: Pharmacy here at Acembia.
- 32:05Speaker 6: Nicole, it's always good to see you.
- 32:07Speaker 10: Good to see you. Thanks for having me on.
- 32:08Speaker 6: Absolutely so.
- 32:10Speaker 3: One of my favorite things in the realm of pharmacy
- 32:14Speaker 3: since I entered a long time ago, over twenty years ago,
- 32:17Speaker 3: is communications, marketing, positioning, branding of not only the services
- 32:22Speaker 3: that I was representing specifically around technology and APIs, but
- 32:29Speaker 3: processes and programs and so when you entered specialty, it's
- 32:35Speaker 3: been a long time, but you've been.
- 32:36Speaker 6: Really aggressive about it.
- 32:37Speaker 3: Over the last two to three years, Finch has emerged
- 32:41Speaker 3: as that company that's really helping to marry the output
- 32:45Speaker 3: the pharmacy itself to a better mouse trap of marketing
- 32:52Speaker 3: and in positioning. So talk to our listeners a little
- 32:54Speaker 3: bit about what Finch is doing here at ASSEMBIA.
- 32:57Speaker 1: Yeah.
- 32:58Speaker 10: So we're excited to be back. It's our second ear
- 33:01Speaker 10: and it's great to just be in the specialty pharmacy
- 33:04Speaker 10: realm because we've been in community pharmacy through our sister
- 33:09Speaker 10: company g RX, but to grow more on the Finch
- 33:12Speaker 10: side with specialty has just been great because I think
- 33:16Speaker 10: it is definitely evolving in a lot of community pharmacies
- 33:19Speaker 10: as well, is getting into the program. But through here,
- 33:23Speaker 10: through Asembia and you know some of our Finch clients
- 33:28Speaker 10: that we've been working with, is just offering that really
- 33:31Speaker 10: targeted approach for specialty pharmacy in the sense of being
- 33:36Speaker 10: able to directly hit prescribers that they're trying to target.
- 33:39Speaker 10: So if they're trying to promote like a specific drug
- 33:42Speaker 10: or program that they're they're using, we can really narrow
- 33:46Speaker 10: down that marketing for them to prescribers by specific specialty
- 33:52Speaker 10: in a certain hospital. I mean, we can get very granular,
- 33:55Speaker 10: which I think is awesome and a great way to
- 33:58Speaker 10: show these companies results over just more ambiguous marketing techniques.
- 34:04Speaker 3: It's a double sided weapon as well, because not only
- 34:07Speaker 3: is gr X supporting the specialty pharmacy in and of itself,
- 34:12Speaker 3: but also the vendor who is marketing to the specialty pharmacy,
- 34:16Speaker 3: so that you can really hone into their messaging and
- 34:18Speaker 3: brand talk to us about kind of both sides of that.
- 34:22Speaker 10: Yeah, So it's yeah, like you said, it's definitely a
- 34:24Speaker 10: two prong approach where we can help those kind of
- 34:27Speaker 10: B to B vendors that are looking to market, but
- 34:30Speaker 10: then bringing those opportunities down to our community pharmacy clients
- 34:34Speaker 10: through gr X because we do have a lot more
- 34:37Speaker 10: of those entering the specialty pharmacy arena. It's kind of
- 34:41Speaker 10: that specialty light mid area between full specialty and retail.
- 34:47Speaker 10: Just because of everything that's going on in the industry.
- 34:49Speaker 10: I think they're you know, looking for other opportunities to
- 34:53Speaker 10: grow their program. So as you know FINCH grows and
- 34:56Speaker 10: continues to bring on more of these B to B clients,
- 35:00Speaker 10: it's just a value added for our gr X ones
- 35:02Speaker 10: because we can say, hey, we've partnered with this great company,
- 35:05Speaker 10: you know, check out their services, and we yeah, can
- 35:07Speaker 10: kind of help through that whole funnel.
- 35:09Speaker 6: All right.
- 35:10Speaker 3: So what challenges are you seeing in specialty pharmacy specifically
- 35:15Speaker 3: in comparison to your experience the sweet spot where you started,
- 35:19Speaker 3: which was community pharmacy.
- 35:22Speaker 10: I think it's just for specialty pharmacies. I mean, in
- 35:25Speaker 10: some way it's it's related to community pharmacy where they're
- 35:29Speaker 10: trying to break through with their larger competitors. So you know,
- 35:33Speaker 10: like how community would have with the chain pharmacy because
- 35:36Speaker 10: there are you know, bigger specialty pharmacy type companies out there,
- 35:41Speaker 10: and we're working with some of the smaller ones. So
- 35:43Speaker 10: helping them kind of break through that that clutter or
- 35:47Speaker 10: that larger focus has been a challenge, but it's definitely
- 35:52Speaker 10: like independence. They bring so much more to the table,
- 35:55Speaker 10: so much more personalized conchiers type services. So helping them
- 36:00Speaker 10: bring that messaging forward to you know, hospitals, prescribers, other manufacturers,
- 36:07Speaker 10: things like that has really been I think valuable for
- 36:11Speaker 10: them and just uplifting their message and help getting it
- 36:13Speaker 10: out more.
- 36:14Speaker 6: No call it.
- 36:15Speaker 3: Before I let you go, I want you to tell
- 36:17Speaker 3: the story that you were talking to me about before
- 36:19Speaker 3: we started recording with a brand new specialty that you're
- 36:22Speaker 3: helping out with their branding and positioning, not only from
- 36:25Speaker 3: a national perspective because they have fifty state aspirations, yeah
- 36:30Speaker 3: and God bless them, that's that's not an easy task,
- 36:33Speaker 3: but also their local branding.
- 36:35Speaker 10: Yeah for sure. So they're a brand new specialty pharmacy,
- 36:39Speaker 10: it's called Rare Specialty. They're in the on the East Coast,
- 36:42Speaker 10: and we actually help them create a logo. I mean
- 36:46Speaker 10: from the very beginning and launch their website, but really
- 36:51Speaker 10: hone in on their local marketing, helping them connect through prescribers.
- 36:55Speaker 10: And we did that through again that targeted marketing approach,
- 36:58Speaker 10: so either email addresses, so emails are going right to
- 37:02Speaker 10: their doctors and it's at the actual first party data,
- 37:06Speaker 10: it's not you know, info at hospital dot com. So
- 37:10Speaker 10: but then we can see those results if that specific
- 37:13Speaker 10: doctor open that email, you know, if they interacted with
- 37:17Speaker 10: the email in any way, so that type of information
- 37:20Speaker 10: we can pass along to the to the client. Uh
- 37:23Speaker 10: So we're doing that with Rare Specialty along with some
- 37:25Speaker 10: LinkedIn ads and other type campaigns, and it's really helped
- 37:29Speaker 10: them kind of grow their local presence and get their
- 37:33Speaker 10: name out there because it's been a two prong approach
- 37:35Speaker 10: of just branding, so helping their name get out there,
- 37:39Speaker 10: but also honing in on specialty certain drugs that they're
- 37:43Speaker 10: really trying to push with prescribers. So it's been fun
- 37:46Speaker 10: to watch them evolve and grow and then yeah, as
- 37:48Speaker 10: they continue to push west and get that fifty state licensure,
- 37:52Speaker 10: we're excited to be a part of that journey along
- 37:55Speaker 10: the way.
- 37:55Speaker 3: All right, listeners, listening right now. They want to reach
- 37:58Speaker 3: out to you. How's the what's the best way to
- 38:00Speaker 3: get a hold of you?
- 38:01Speaker 10: They can reach us at Finch Marketingsolutions dot com.
- 38:04Speaker 3: Finch Marketingsolutions dot com. You hear it, You heard it here.
- 38:08Speaker 3: Access to Pharmacy twenty twenty five. Thanks Nicole for being
- 38:11Speaker 3: on the show.
- 38:12Speaker 1: Yep, thank you.
- 38:18Speaker 11: Pop Quiz time. What year was the Pharmacy Podcast Network founded?
- 38:21Speaker 11: Super fans got this one right away, but we give
- 38:23Speaker 11: everyone a second to think. If you said two thousand
- 38:28Speaker 11: and nine, well thanks loyal listener.
- 38:35Speaker 3: The Internet, my gosh, I remember, I don't know. Nineteen
- 38:40Speaker 3: ninety nine, I was in telecom. I was selling something
- 38:43Speaker 3: called frame relay, which is one of the most boring
- 38:45Speaker 3: things I've ever done in my life. And then the
- 38:47Speaker 3: Internet comes out and it kind of like changes literally everything,
- 38:52Speaker 3: A relationship that I have with a friend that I've
- 38:54Speaker 3: watched her family grow up as Chara, welcome to Access
- 38:59Speaker 3: twenty five. I have access to pharmacy and our post
- 39:02Speaker 3: show charts.
- 39:03Speaker 5: Nice to see you, Great to see you too, Tad.
- 39:06Speaker 6: This is exciting, isn't it funny?
- 39:07Speaker 3: How social media has in one way in my opinion,
- 39:12Speaker 3: because I'm a parent just like you. I think when
- 39:15Speaker 3: you and I grew up, we didn't have it, but
- 39:18Speaker 3: then we add it to our lives now, and I
- 39:20Speaker 3: think it means more to us as people who knew
- 39:23Speaker 3: how to communicate without it, where whereas now, you know,
- 39:27Speaker 3: I got to meet you through in our and what
- 39:30Speaker 3: your family grow up and what's your successes at Sincora
- 39:33Speaker 3: and what's your own career growth. That means something to
- 39:35Speaker 3: me because I'm the same professional as you, so I
- 39:39Speaker 3: want to see you being having success in your space.
- 39:42Speaker 3: But then I think of my kids and they've saturated
- 39:46Speaker 3: in internet and social media for so long. But what
- 39:48Speaker 3: do you think about that whole thing as a parent
- 39:50Speaker 3: in the world of internet.
- 39:52Speaker 12: Yeah, you know, that's that's interesting to actually think through
- 39:56Speaker 12: kind of being that sandwich generation, you know, kind of
- 40:00Speaker 12: growing up without the Internet and then getting to a
- 40:03Speaker 12: point in very early adulthood, late teens, depending on your age,
- 40:08Speaker 12: where there becomes social media and it and it changed
- 40:13Speaker 12: literally it changed our lives, you know, in ways I
- 40:15Speaker 12: don't think we ever could have imagined. I definitely do
- 40:19Speaker 12: remember when connecting with someone on the Internet that you
- 40:23Speaker 12: didn't actually know in real life was a little bit creepy, yes,
- 40:26Speaker 12: like it wasn't a thing that like you were just
- 40:29Speaker 12: like ew, I don't know this person.
- 40:31Speaker 5: Why are they trying to be my friend?
- 40:34Speaker 12: Like that's weird and to change like this is the
- 40:37Speaker 12: way that we connect and taking that back to our
- 40:41Speaker 12: kids only knowing this way to connect, I mean, we
- 40:44Speaker 12: still do have to put a lot of guardrails because
- 40:46Speaker 12: they are children, right and so there are you know
- 40:50Speaker 12: there there could for sure be things that we or
- 40:52Speaker 12: people we don't want them to connect with, but they're
- 40:55Speaker 12: so trusting because this is the world that that they've
- 40:58Speaker 12: grown up in, and so I think it gave it
- 41:01Speaker 12: still gives me a pause of what are what's safe
- 41:06Speaker 12: you know, for children to do, But then also have
- 41:09Speaker 12: a true appreciation on how connected we can be and
- 41:15Speaker 12: through these connections, how we have been able to do
- 41:21Speaker 12: so much, so many incredible things for patients and patient
- 41:24Speaker 12: care because of the arc of learning, we've taken that
- 41:30Speaker 12: runway and it's now a step which I would even
- 41:33Speaker 12: boil down to say, it's now a click. Truly, it's
- 41:38Speaker 12: a clique, you know, which is just wild. It's mind blowing,
- 41:43Speaker 12: but I think in a really good way. But it
- 41:46Speaker 12: will be interesting as we see how these kids who
- 41:51Speaker 12: kind of just grew up with this being part of
- 41:53Speaker 12: their life, how they navigate early adulthood and in their careers.
- 41:59Speaker 12: And and I do also wonder if it'll go backwards
- 42:04Speaker 12: a little bit where they actually do want more in
- 42:07Speaker 12: person connections than so many virtual connections. I do wonder
- 42:12Speaker 12: if there'll be some sort of path backwards.
- 42:15Speaker 3: Yeah, I agree, And I'm seeing shifts in how we
- 42:19Speaker 3: work as professionals. We are at Access twenty five. Assembia
- 42:24Speaker 3: is like the super Bowl event of specialty pharmacy business
- 42:27Speaker 3: Sincora aka Americasursbergen has been a supporter of this event forever,
- 42:33Speaker 3: and your career has blossomed and has changed and has
- 42:39Speaker 3: evolved been I think I've been connected to you for
- 42:42Speaker 3: like ten years now, and it's just amazing to see
- 42:44Speaker 3: you make the corner and they come and walking down
- 42:48Speaker 3: our aisle, and I was so excited to see you
- 42:50Speaker 3: because I just we don't get enough time together in person.
- 42:54Speaker 3: We're always just defaulting to our internet connection. But talk
- 42:58Speaker 3: to me about the important of being involved in the
- 43:01Speaker 3: super Bowl of a specialty pharmacy.
- 43:04Speaker 12: Yeah, this really is the super Bowl conference, and this
- 43:07Speaker 12: is a conference that's truly near and dear to our
- 43:10Speaker 12: organization because of the connectivity that it brings that instead
- 43:15Speaker 12: of us doing what we do so often being virtual,
- 43:19Speaker 12: it does allow us to have those in person connections
- 43:22Speaker 12: and meetings and whiteboarding and brainstorming, because truly, at Sincora,
- 43:28Speaker 12: our goal is to create healthier futures. That is our
- 43:32Speaker 12: responsibility and we take that charge very very seriously, and
- 43:36Speaker 12: we are a proud sponsor of this conference.
- 43:39Speaker 5: Because it helps us do just that.
- 43:42Speaker 12: And we know that the impact that we all have
- 43:45Speaker 12: collectively together by attending the sessions, by walking the exhibit hall,
- 43:50Speaker 12: by sitting in the meetings, by even breaking bread.
- 43:53Speaker 5: I mean, I've had so many.
- 43:55Speaker 12: Great grab a coffee, grab a lunch, go to dinner
- 43:59Speaker 12: conversation that excites me for when I go back home
- 44:04Speaker 12: and on Monday, I get back to work and think
- 44:06Speaker 12: through the learnings that I've had, the takeaways that I've
- 44:10Speaker 12: taken out of meetings, the new connections that I've had,
- 44:14Speaker 12: and the reconnections to people that I've known that I
- 44:17Speaker 12: just don't get to see that often. I think it
- 44:19Speaker 12: charges us all back up again to go back on
- 44:24Speaker 12: Monday and take back some things that are going to
- 44:27Speaker 12: be important for us as we do move.
- 44:29Speaker 5: Forward with our work day.
- 44:31Speaker 12: And truly all I don't think there's any person that's
- 44:34Speaker 12: here that's not here because they know that at the
- 44:38Speaker 12: end of the day, what happened here is going to
- 44:41Speaker 12: impact patients' lives and that is extremely important to me.
- 44:46Speaker 3: Yep, And it's the support of the professional. We are
- 44:49Speaker 3: leaving our families, we're leaving our comfort zones, We're coming here.
- 44:54Speaker 3: Vegas is not an easy place to get to per
- 44:58Speaker 3: se in some ways, and but when we get here
- 45:01Speaker 3: and we fuse together, we start brainstorming together. There's an
- 45:05Speaker 3: energy and something that Sincora did this year at Assembia
- 45:09Speaker 3: that was very special is you set up a professional
- 45:12Speaker 3: photography group in your booth so that someone that wants
- 45:16Speaker 3: to change their LinkedIn profile or they want to do
- 45:19Speaker 3: something with this headshot that's important in being able to
- 45:23Speaker 3: show yourself as professionally as possible. And that brought a
- 45:26Speaker 3: lot of attention to you guys.
- 45:28Speaker 12: Yeah, I thought it was a great idea that our
- 45:32Speaker 12: marketing team decided to do the photo booth this year,
- 45:36Speaker 12: and I did go down there and I was with
- 45:38Speaker 12: the colleague who got new pictures and they looked amazing,
- 45:43Speaker 12: and so I'm excited to see her new pictures. But
- 45:45Speaker 12: we also got to connect with people. We got to
- 45:47Speaker 12: connect with some colleagues that were standing down there. We
- 45:50Speaker 12: got to connect with some ASSEMBIA team members that were
- 45:54Speaker 12: down there to get their pictures, you know, taken. And
- 45:57Speaker 12: so just while standing in line, you are still connecting.
- 46:00Speaker 12: And even though it sounds very simple, you know, to
- 46:03Speaker 12: go get a picture taken, I think it still provides
- 46:07Speaker 12: another way to connect and do what we do best
- 46:11Speaker 12: in healthcare. And these connections are truly you can't put
- 46:15Speaker 12: a price tag on it. It's been priceless.
- 46:17Speaker 3: Absolutely try to read Sincora special to see you, spend
- 46:22Speaker 3: some time with you. Thanks for being part of the
- 46:24Speaker 3: Access twenty five post show.
- 46:26Speaker 5: Thank you so much, Todd. That's truly been my pleasure.
- 46:30Speaker 6: Thank you.
- 46:34Speaker 3: Donnie's back on the pods. It's great to see you.
- 46:38Speaker 13: Thank you.
- 46:38Speaker 8: Dot.
- 46:39Speaker 3: We were in Nashville last time. Now we're here in Vegas.
- 46:43Speaker 3: I hate Vegas by the way, I'm just gonna be honest.
- 46:45Speaker 13: Did you lose all the money again?
- 46:47Speaker 6: No, it's not that. It's just a it's just not
- 46:49Speaker 6: my vibe. Like I'm a beach person.
- 46:51Speaker 3: So why can't we have this in Naples or you know,
- 46:53Speaker 3: on the on San Diego or something like that.
- 46:56Speaker 6: No, this conference is my.
- 46:58Speaker 3: Favorite actualty business conference because people come here to do business.
- 47:04Speaker 3: This is their entire mind. They're not here for clinical
- 47:07Speaker 3: per se. There's a little bit of that sprinkled in,
- 47:09Speaker 3: but this is about let's execute, let's do things that
- 47:13Speaker 3: are going to make sense for our patients. So when
- 47:15Speaker 3: I think of URS for ROUTE and what you guys
- 47:17Speaker 3: are doing for logistics and technology in the specialty space,
- 47:22Speaker 3: talk to us about how your organization has stepped up
- 47:25Speaker 3: and really helped out specialty pharmacy with us.
- 47:28Speaker 13: Helping with us to the specialty pharmacies is the main
- 47:30Speaker 13: key point of RX FAR Route is obviously the handling
- 47:34Speaker 13: deliveries and helping specialty pharmacies with everything regarding deliveries from
- 47:39Speaker 13: top to bottom, starting with the signatures and ending with
- 47:43Speaker 13: delivering the cold packages.
- 47:45Speaker 3: I also think, Donnie, about your integration with the pharmacy
- 47:48Speaker 3: management systems that.
- 47:49Speaker 6: Are out there.
- 47:50Speaker 3: Talk about those relationships because that's super important.
- 47:52Speaker 13: Sure we are integrated with all major PMS systems that
- 47:57Speaker 13: are out there, Pioneer, Prime, SUITO, xp st REX, McKesson
- 48:02Speaker 13: all DPMs systems that are out there. It's a two
- 48:04Speaker 13: way integration. It's the best integration that's currently on the market.
- 48:08Speaker 13: None of the other companies have what we have. The
- 48:10Speaker 13: relationship that we've built not only with the other pharmacies
- 48:13Speaker 13: but as well as other pharmacy software managements. That's how
- 48:17Speaker 13: we're able to get the two way integration that helps
- 48:19Speaker 13: pharmacies sufficiently cutting the cost by saving the time on
- 48:23Speaker 13: creating the orders and helps them with the audits as well.
- 48:26Speaker 13: Because the signature is coming back, you don't have to
- 48:28Speaker 13: worry about anything.
- 48:30Speaker 3: All right, So especially a little bit different of a beast.
- 48:34Speaker 3: I'm the prescriber, I execute on the medication. I want
- 48:38Speaker 3: this thing filled and I want it to my patient asap.
- 48:42Speaker 3: So talk to me about the environment of what ARCS
- 48:45Speaker 3: for Route is doing specifically in specialty to ensure that
- 48:49Speaker 3: that patient is on the MET as quickly as possible.
- 48:52Speaker 13: To ensure that person is on the met as possible.
- 48:54Speaker 13: Us compared to all the other delivery systems that you
- 48:58Speaker 13: might have, or that you might use use, or that
- 49:00Speaker 13: you might heard of, we are specifically designed only on
- 49:04Speaker 13: delivery medications, and we've built it only for the medication.
- 49:08Speaker 13: We don't deliver food, we don't deliver cloth. It's only
- 49:10Speaker 13: for the medications, right. So as well as creating the orders,
- 49:13Speaker 13: there's a bunch of different steps that you can take.
- 49:16Speaker 13: There's a bunch of different settings that you can toggle
- 49:18Speaker 13: on and off to make sure that the software is
- 49:20Speaker 13: really optimized for your needs. It is not a one
- 49:23Speaker 13: shoe that fits all. We come in, we toggle all
- 49:27Speaker 13: the settings. We make sure that if this patient is
- 49:29Speaker 13: a STAT whenever you create this patient or whenever you
- 49:32Speaker 13: use this drug, our system will automatically much considered as
- 49:36Speaker 13: a STAT order and make sure that the patient gets
- 49:39Speaker 13: it as soon as possible as they need to.
- 49:41Speaker 3: Is this ARCS for routes first ASSEMBIA, second second ASSEMBIA.
- 49:47Speaker 3: So in differentiating from GUN to NCPA APHA some of
- 49:52Speaker 3: the things. What do you think about this event specifically
- 49:55Speaker 3: for specialty.
- 49:57Speaker 13: This one is more of networking event, I would say,
- 50:01Speaker 13: and the more oriented for a specialisty pharmacies. I haven't
- 50:05Speaker 13: had any long term care, any retail, any of the
- 50:09Speaker 13: other pharmacy specialties, and I think this is one of
- 50:14Speaker 13: the best conferences that a specialty pharmacy could attend.
- 50:17Speaker 3: Absolutely, and you just shouted out the different sectors that
- 50:20Speaker 3: you help, not only in delivery and logistics, but also
- 50:25Speaker 3: your sister company that focuses on staffing, which is how
- 50:28Speaker 3: you helped the Pharmacy podcast out over at APHA twenty
- 50:32Speaker 3: twenty five. So if you are listening right now and
- 50:36Speaker 3: you're interested in working with Donnie Donnie, give them the
- 50:39Speaker 3: best place to go to learn more about your organization.
- 50:42Speaker 3: R X four route dot com our x four route
- 50:46Speaker 3: dot com.
- 50:47Speaker 6: We're gonna put it in the show notes. Donnie. Once again,
- 50:49Speaker 6: thanks for being part of the show.
- 50:51Speaker 3: Of course, thank you, Tod, Chris Corsi, Cassie and how
- 50:58Speaker 3: Cassie and r EX We're at ZEMBIA twenty twenty five.
- 51:01Speaker 3: I want to jump right in. We've talked before, but
- 51:04Speaker 3: I want to know specifically around specialty pharmacy. Give our
- 51:07Speaker 3: listeners the connection of how Cassie and RX is dialing
- 51:11Speaker 3: into specially specifically.
- 51:12Speaker 14: Yeah, definitely. So Cassian has a purpose built and the
- 51:15Speaker 14: specialty platform, and with that platform, we're connecting all the
- 51:19Speaker 14: different stakeholders. So we have the physicians, the patients and
- 51:23Speaker 14: the pharmacists all working in the end end platform and
- 51:26Speaker 14: have streamline communication channels between all of them to help
- 51:29Speaker 14: accelerate access, to improve it here and to do everything
- 51:32Speaker 14: that you know all the different stakeholders are looking for.
- 51:34Speaker 3: Is this based on a system that would have an
- 51:36Speaker 3: API to another pharmacy management system or an electronic health record?
- 51:40Speaker 14: Exactly right, We fully integrate into your pharmacy dispensing platform
- 51:44Speaker 14: or even EMRs.
- 51:45Speaker 3: Yeah, okay, And then where do you focus specifically on specially?
- 51:49Speaker 3: Have you found a disease state that you're managing in
- 51:52Speaker 3: a special way? Are you are you finding logistics as
- 51:56Speaker 3: the is the hurdle? Where is cassium rix? Where are
- 52:01Speaker 3: you guys dialing in into specially specifically?
- 52:04Speaker 14: Yeah, we work across a lot of different disease states.
- 52:06Speaker 14: We have a big immunology portfolio and oncology that primarily
- 52:10Speaker 14: those main two areas is where we have most of
- 52:12Speaker 14: our patients, but we really cross caught all the different
- 52:15Speaker 14: disease categories and therapeutic areas.
- 52:17Speaker 3: When you're here at a sembia where this is like
- 52:19Speaker 3: the super bowl of specialty pharmacy business, what are you
- 52:23Speaker 3: learning at a conference like this where the gaps are
- 52:26Speaker 3: to help patients get their medication faster, get information back
- 52:30Speaker 3: to our physicians, report things back to the manufacturer with
- 52:33Speaker 3: like REMS issues or RIMS reporting, and then obviously really
- 52:37Speaker 3: being concerned with workflow of how it's impacting specialty pharmacy operations.
- 52:41Speaker 14: Yeah, that's a good question, right, I mean it's a
- 52:43Speaker 14: tough answer. I mean, we see it everywhere. Right, That's
- 52:47Speaker 14: why we've kind of built that purpose specialty pharmacy platform.
- 52:50Speaker 14: So it's all one end to end platform because before right,
- 52:53Speaker 14: it was jump into this, jump out of that, jump
- 52:55Speaker 14: into this. And when you have all those stakeholders all
- 52:58Speaker 14: into the one platform and synergistically working together, you really
- 53:03Speaker 14: alleviate a lot of those burdens. The patient understands where
- 53:06Speaker 14: they're at through the whole PA process all the way
- 53:08Speaker 14: through their last refill on that script, the physician has
- 53:12Speaker 14: a view, I like to say, a window into where
- 53:14Speaker 14: the pharmacy is at, where that patient is in that
- 53:16Speaker 14: journey as well, So the physician is connected into that
- 53:19Speaker 14: journey now, so you're building a joint care team between
- 53:21Speaker 14: the pharmacists and the physician. So really we're trying to
- 53:24Speaker 14: alleviate all those barriers right now in that ecosystem with
- 53:27Speaker 14: our platform. So, I mean I think it's cut across
- 53:30Speaker 14: everything and I think we're helping in a lot of
- 53:32Speaker 14: different areas there, especially facilitating and communicating. When you asked
- 53:35Speaker 14: about the burden on the pharmacy, right, how does this
- 53:39Speaker 14: how does this affect the pharmacy? Being all in one system, right,
- 53:43Speaker 14: it really helps the pharmacy. Like I said, you're not
- 53:46Speaker 14: jumping in and out of different platforms. Now we can
- 53:48Speaker 14: integrate directly into your dispensing platform or work standalone if
- 53:52Speaker 14: you would just want to have side by side platform.
- 53:54Speaker 14: So we really try to put the pharmacy first and
- 53:56Speaker 14: create the pharmacy as like the hub of all the
- 54:00Speaker 14: services and bring all those stakeholders to the pharmacy so
- 54:02Speaker 14: that the pharmacy can operate efficiently in that ecosystem.
- 54:05Speaker 3: All right, specially pharmacists operations listening right now, they're listening
- 54:10Speaker 3: to what you're saying or peaking their interest.
- 54:12Speaker 6: What's the best way to reach out to you?
- 54:14Speaker 14: Shoot me an email at Chris dot Corsi at cassieanrx
- 54:16Speaker 14: dot com.
- 54:17Speaker 3: Excellent, excellent, and then you're on LinkedIn, so look up
- 54:20Speaker 3: Chris on LinkedIn as well. Cassieanrx dot com.
- 54:25Speaker 6: Yeah, thank you.
- 54:30Speaker 3: A big part of specialty pharmacy, something very important is
- 54:34Speaker 3: when the patient runs into a brick wall when it
- 54:37Speaker 3: comes to their finances and being able to get things
- 54:41Speaker 3: paid for. And this network has been very sensitive to
- 54:45Speaker 3: things like that. Very excited to run into Michael email,
- 54:49Speaker 3: who is the CEO of Health Well Foundation. Michael, welcome
- 54:55Speaker 3: to the show.
- 54:55Speaker 15: Hey, thank you Todd, Thanks for having me.
- 54:57Speaker 6: All right, let's get into this.
- 54:58Speaker 3: So, boy, I have four daughters, So I think if
- 55:03Speaker 3: one of my daughters were sick and they needed especially
- 55:07Speaker 3: med it starts putting financial pressures on my family that
- 55:11Speaker 3: in itself creates even more problems than other things that
- 55:15Speaker 3: are taking place in her health. Talk to me about
- 55:19Speaker 3: those kinds of stresses on people out there who have
- 55:23Speaker 3: some kind of rare disease need the assistance, and how
- 55:27Speaker 3: health Well Foundation is helping out and thanks.
- 55:31Speaker 15: Financial toxicity is a real problem in the healthcare industry
- 55:37Speaker 15: and creates a lot of additional problems beyond the disease
- 55:42Speaker 15: that the patient may be suffering, whether it be mental health, stress,
- 55:47Speaker 15: lack of sleep. What we know from surveys. We recently
- 55:51Speaker 15: surveyed a thousand of our patients. Forty one percent said
- 55:54Speaker 15: without financial assistance, they would not be able to take
- 55:58Speaker 15: their prescription drugs. Thirty seven percent of those patients told
- 56:03Speaker 15: us that without financial assistance from a foundation like Health Well,
- 56:07Speaker 15: they wouldn't eat, they would change their grocery habits so
- 56:11Speaker 15: they would have a lower nutritional status. And we see
- 56:13Speaker 15: this unfortunately all the time with cancer patients, autoimmune patients,
- 56:19Speaker 15: patients with rare diseases, where they're making choices between taking
- 56:24Speaker 15: their prescriptions as instructed, or paying their rent, buying healthy food,
- 56:30Speaker 15: and a number of other things that help them in
- 56:33Speaker 15: So there's really no need for somebody to have to
- 56:36Speaker 15: cut a pill in half and not take it as
- 56:39Speaker 15: prescribed when there's organizations like Health Wealth that can offer
- 56:44Speaker 15: financial assistance.
- 56:45Speaker 3: Michael, talk to me about how you work with specialty
- 56:47Speaker 3: pharmacies to get them to understand what your programs are
- 56:50Speaker 3: and then where to insert them into the ecosystem of
- 56:56Speaker 3: everything that's happening with that patient's life.
- 56:58Speaker 15: Yeah, pharmacists are incredible important to our ability to help
- 57:02Speaker 15: patients because about a third of our referrals come from
- 57:05Speaker 15: the pharmacy community, and a pharmacist having a patient at
- 57:10Speaker 15: the window or counseling a patient in a clinic or
- 57:13Speaker 15: in a health system where that patient can't afford the
- 57:17Speaker 15: medication and they see the price for the first time
- 57:21Speaker 15: needs to know that there are resources out there to
- 57:23Speaker 15: help those patients. And so about thirty three percent of
- 57:27Speaker 15: our referrals come from pharmacists. Another third of our referrals
- 57:30Speaker 15: come from provider organizations. So it's absolutely critical that we
- 57:35Speaker 15: continue to get the word out about health well to
- 57:38Speaker 15: the pharmacy community and the specialty pharmacy community in particular,
- 57:42Speaker 15: so that we can continue to help patients excellent.
- 57:45Speaker 3: So talk to me about the extension of your reach.
- 57:50Speaker 3: Specialty pharmacy are also assisting in the community space or
- 57:54Speaker 3: long term care pharmacy, Does it really even matter.
- 57:57Speaker 15: It doesn't matter wherever the patient need is getting. Building
- 58:02Speaker 15: a network of people who have access to patients who
- 58:06Speaker 15: need help, most commonly pharmacists, but providers, nursing case managers,
- 58:13Speaker 15: social workers that all work in the chronic disease and
- 58:16Speaker 15: rare disease space assistant patients are critical to us. We
- 58:21Speaker 15: spend a tremendous amount of time building an alliance network
- 58:26Speaker 15: of a number of different nonprofit organizations that can assist
- 58:32Speaker 15: where we've been in conversations about joining the National Association
- 58:36Speaker 15: of Specialty pharmacists so we can get our word out better.
- 58:39Speaker 15: Of fact, I'll be meeting with their team while we're
- 58:41Speaker 15: here at ASSEMBIA this week and then offering portal accounts
- 58:47Speaker 15: into our system for specialty pharmacies so that we can
- 58:51Speaker 15: streamline the process. The pharmacists can help enroll the patient
- 58:56Speaker 15: in one of our disease funds, and we can get
- 58:58Speaker 15: the copay into the hands of the pharmacy or the
- 59:03Speaker 15: patient right upon approval of the application.
- 59:07Speaker 3: Michael, the Access to twenty five conference. ASSEMBIA twenty twenty
- 59:12Speaker 3: five is my favorite business conference in specialty pharmacy other
- 59:16Speaker 3: than the NASP. Shout out to Sheila Arquette. Actually, NASP
- 59:20Speaker 3: is a part of our network. We value all the data,
- 59:23Speaker 3: all the information that she brings and her team brings
- 59:26Speaker 3: are just amazing. But what are you looking forward to
- 59:29Speaker 3: at this meeting this year?
- 59:31Speaker 15: This is my first ASSEMBIA. I spent thirty eight years
- 59:33Speaker 15: working in the hospital in health system space. I joined
- 59:37Speaker 15: health Well about six months ago and I'm still learning
- 59:40Speaker 15: more and more about what we do as a foundation
- 59:43Speaker 15: to help patients and really about some of the challenges
- 59:47Speaker 15: within the specialty pharmacy community and so connecting with as
- 59:51Speaker 15: many people as I can building those networks and listening
- 59:56Speaker 15: to what providers here are patients need so that we
- 1:00:01Speaker 15: can then work to expand the funds that we offer
- 1:00:05Speaker 15: to patience.
- 1:00:06Speaker 3: That's wonderful, Michael, thank you for being part of the
- 1:00:08Speaker 3: post show here on the Pharmacy Podcast Network.
- 1:00:11Speaker 6: We appreciate this.
- 1:00:12Speaker 15: Thank you very much.
- 1:00:13Speaker 6: Tons Alicia, it's so good to see you.
- 1:00:19Speaker 3: I only get to communicate with you on the world
- 1:00:22Speaker 3: of LinkedIn, which is great because at least we get
- 1:00:24Speaker 3: to meet, but we don't get to see each other
- 1:00:26Speaker 3: in person lots, and I love talking with you in person.
- 1:00:29Speaker 1: Yeah, it's great to be here. Thanks for having me on.
- 1:00:32Speaker 3: All right, so you've been on the show. It's been
- 1:00:34Speaker 3: too long, so now give us an update. What are
- 1:00:37Speaker 3: you doing with MCPDP, And I mean, that was a
- 1:00:40Speaker 3: marriage made in heaven for you to match up with them,
- 1:00:43Speaker 3: so talk to me about that.
- 1:00:44Speaker 1: Yeah, it really was.
- 1:00:45Speaker 16: I think the last time we spoke, I was still
- 1:00:47Speaker 16: with Point of Care Partners doing the consulting thing. So
- 1:00:50Speaker 16: back then, you know, I was doing a lot of
- 1:00:53Speaker 16: industry work of trying to figure out how MCPDP could
- 1:00:56Speaker 16: support the expanding role of the pharmacists. You know, kind
- 1:00:59Speaker 16: of thinking more beyond the standards. And so when the
- 1:01:02Speaker 16: role opened up, UH to do this, I it just seemed.
- 1:01:05Speaker 1: Like, like you said, a perfect fit.
- 1:01:07Speaker 16: So my my role right now is to really be
- 1:01:11Speaker 16: involved with the industry happenings, what's going on. Of course,
- 1:01:15Speaker 16: we're all us going to have our standards, but there's
- 1:01:17Speaker 16: so much going on in terms of pharmacist supporting, clinical services,
- 1:01:21Speaker 16: care coordination, chronic care management, and we're trying to understand
- 1:01:25Speaker 16: as MCPEP how we can support that, either through our
- 1:01:28Speaker 16: standards or through partnerships with you know, other industry organizations,
- 1:01:33Speaker 16: you know, bringing health plans into the fold, bringing more
- 1:01:37Speaker 16: pharmacists into you know, into talk about really what they
- 1:01:40Speaker 16: need to support all those additional things that they're doing.
- 1:01:43Speaker 3: So we're at a sembia specialty pharmacies at the mind
- 1:01:47Speaker 3: talk to us specifically about ncpd's positioning in specialty farms.
- 1:01:51Speaker 6: Yeah.
- 1:01:52Speaker 16: So actually when I was a so when I was
- 1:01:56Speaker 16: just a member, I actually started the Specialty work Group
- 1:02:00Speaker 16: at NCPDP and the thing that we tried to do
- 1:02:03Speaker 16: is come up with standards. Right, we know that specialty pharmacy,
- 1:02:06Speaker 16: there's other additional standards that need to be out there
- 1:02:10Speaker 16: to support specialty pharmacy. So we have quite a few
- 1:02:15Speaker 16: of our standards that support specialty, but also thinking about
- 1:02:18Speaker 16: again kind of the clinical services that go along with
- 1:02:21Speaker 16: the specialty medications. You know, you don't just dispense the
- 1:02:25Speaker 16: specialty med there's all sorts of additional services and follow
- 1:02:29Speaker 16: up and you know, management of the patient that needs
- 1:02:31Speaker 16: to happen. So I'm here really to learn and to
- 1:02:34Speaker 16: talk to people about kind of what they're doing and how.
- 1:02:37Speaker 1: They're doing it.
- 1:02:38Speaker 3: That's good because when we can fit this together under
- 1:02:41Speaker 3: these standards, now all of the workflow companies are now
- 1:02:45Speaker 3: on the same language, all of our pharmacy management systems,
- 1:02:49Speaker 3: our payers understand the value more now we're connecting to
- 1:02:52Speaker 3: getting things paid for. So it's it's the gel that
- 1:02:55Speaker 3: I've watched come together through NCPDP on all facets of
- 1:02:59Speaker 3: fire pharmacy started in my realm and the work A
- 1:03:03Speaker 3: shout out to Work Group fourteen for the long term
- 1:03:05Speaker 3: care pharmacy Shelley Spyro just to shut out to Shelley,
- 1:03:09Speaker 3: but yes, now it's important to see where this is
- 1:03:12Speaker 3: going specifically and specially because especially he's expanding.
- 1:03:16Speaker 16: Absolutely, it absolutely is and it's great to you know,
- 1:03:19Speaker 16: I remember last year and even this year, there was
- 1:03:22Speaker 16: never talk about prior authorization. Right, we can do prior
- 1:03:25Speaker 16: authorization electronically. I just came up from a session where
- 1:03:29Speaker 16: they're talking about transparency and better understanding even the pricing
- 1:03:32Speaker 16: of specialty meds. So all of that ties into our
- 1:03:35Speaker 16: standards and the things that we do at in CPDP.
- 1:03:38Speaker 3: All right, how do people listening want to actually connect
- 1:03:42Speaker 3: with you? I know you're big in LinkedIn, but how
- 1:03:45Speaker 3: should listeners reach out?
- 1:03:46Speaker 1: Yeah, so reach out to me on LinkedIn.
- 1:03:48Speaker 16: Otherwise, if you go to our website INCPDP dot org,
- 1:03:52Speaker 16: we're actually just going to be launching our new strategic
- 1:03:55Speaker 16: plan at our annual conference next week. So it's all
- 1:03:58Speaker 16: about kind of clinical data exchange. It's about supporting the
- 1:04:02Speaker 16: expanding role of the pharmacist. So you can go on
- 1:04:05Speaker 16: our website learn more and contact us through there if
- 1:04:08Speaker 16: you want to get involved. We have a lot of
- 1:04:10Speaker 16: new committees, subcommittees and a lot of focus on pharmacy
- 1:04:13Speaker 16: innovation starting in the next year.
- 1:04:16Speaker 3: That's great, excellent and fringe benefit of this NCPDP. Often
- 1:04:21Speaker 3: do you get to go to Scottsdale? I actually live
- 1:04:24Speaker 3: ah all right. We left one of the most beautiful
- 1:04:27Speaker 3: places on earth, so I love weather.
- 1:04:28Speaker 6: It's going to be good, all right.
- 1:04:31Speaker 3: Thanks for being part of the Access twenty twenty five
- 1:04:34Speaker 3: show here at Ascembia.
- 1:04:36Speaker 1: Yeah, thank you for having me.
- 1:04:37Speaker 6: Thank you.